Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Olfson

Showing results (291-300 of 684) with videos related to

Pageof 69
Sort By:
Health Affairs (Project Hope)|January 8, 2019
Medication Treatment For Opioid Use Disorders In Substance Use Treatment FacilitiesRamin Mojtabai, Christine Mauro, Melanie M Wall, et al.
The American Journal of Psychiatry|March 22, 2017
Suicide Following Deliberate Self-HarmMark Olfson, Melanie Wall, Shuai Wang, et al.
Plos Computational Biology|March 13, 2023
Hindcasts and forecasts of suicide mortality in US: A modeling studySasikiran Kandula, Mark Olfson, Madelyn S Gould, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 26, 2021
Suicide risk in first year after dementia diagnosis in older adultsTimothy Schmutte, Mark Olfson, Donovan T Maust, et al.
Drug and Alcohol Dependence|December 11, 2020
Outpatient prescribing of opioids to adults diagnosed with mental disorders in the United StatesMatthew T Taylor, Daniel B Horton, Theresa Juliano, et al.
JAMA Psychiatry|January 6, 2021
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine LearningÁngel García de la Garza, Carlos Blanco, Mark Olfson, et al.
Psychiatric Services (Washington, D.C.)|May 1, 2019
The Affordable Care Act and Opioid Agonist Therapy for Opioid Use DisorderRamin Mojtabai, Christine Mauro, Melanie M Wall, et al.
Plos One|October 9, 2020
Private health insurance coverage of drug use disorder treatment: 2005-2018Ramin Mojtabai, Christine Mauro, Melanie M Wall, et al.
Medicine|October 29, 2021
Psychotropic medication prescribing during the COVID-19 pandemicMatthew E Hirschtritt, Natalie Slama, Stacy A Sterling, et al.
American Journal of Preventive Medicine|March 11, 2023
Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability BeneficiariesHillary Samples, Molly A Nowels, Arthur R Williams, et al.
Pageof 69

Showing results (291-300 of 684) with videos related to

Sort By:
Pageof 69
Health Affairs (Project Hope)|January 8, 2019
Medication Treatment For Opioid Use Disorders In Substance Use Treatment FacilitiesRamin Mojtabai, Christine Mauro, Melanie M Wall, et al.
The American Journal of Psychiatry|March 22, 2017
Suicide Following Deliberate Self-HarmMark Olfson, Melanie Wall, Shuai Wang, et al.
Plos Computational Biology|March 13, 2023
Hindcasts and forecasts of suicide mortality in US: A modeling studySasikiran Kandula, Mark Olfson, Madelyn S Gould, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 26, 2021
Suicide risk in first year after dementia diagnosis in older adultsTimothy Schmutte, Mark Olfson, Donovan T Maust, et al.
Drug and Alcohol Dependence|December 11, 2020
Outpatient prescribing of opioids to adults diagnosed with mental disorders in the United StatesMatthew T Taylor, Daniel B Horton, Theresa Juliano, et al.
JAMA Psychiatry|January 6, 2021
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine LearningÁngel García de la Garza, Carlos Blanco, Mark Olfson, et al.
Psychiatric Services (Washington, D.C.)|May 1, 2019
The Affordable Care Act and Opioid Agonist Therapy for Opioid Use DisorderRamin Mojtabai, Christine Mauro, Melanie M Wall, et al.
Plos One|October 9, 2020
Private health insurance coverage of drug use disorder treatment: 2005-2018Ramin Mojtabai, Christine Mauro, Melanie M Wall, et al.
Medicine|October 29, 2021
Psychotropic medication prescribing during the COVID-19 pandemicMatthew E Hirschtritt, Natalie Slama, Stacy A Sterling, et al.
American Journal of Preventive Medicine|March 11, 2023
Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability BeneficiariesHillary Samples, Molly A Nowels, Arthur R Williams, et al.
Pageof 69